Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 8, 2020 - The FDA announced the approval of Eli Lilly’s Retevmo (selpercatinib).
Download PDF
Return to publications
